System Quality & Patient Safety, Houston Methodist Hospital System, Houston, TX, United States.
Center for Outcomes Research, Houston Methodist Research Institute, Houston, TX, United States.
JMIR Mhealth Uhealth. 2020 Jun 26;8(6):e19333. doi: 10.2196/19333.
Despite the growth of and media hype about mobile health (mHealth), there is a paucity of literature supporting the effectiveness of widespread implementation of mHealth technologies.
This study aimed to assess whether an innovative mHealth technology system with several overlapping purposes can impact (1) clinical outcomes (ie, readmission rates, revisit rates, and length of stay) and (2) patient-centered care outcomes (ie, patient engagement, patient experience, and patient satisfaction).
We compared all patients (2059 patients) of participating orthopedic surgeons using mHealth technology with all patients of nonparticipating orthopedic surgeons (2554 patients). The analyses included Wilcoxon rank-sum tests, Kruskal-Wallis tests for continuous variables, and chi-square tests for categorical variables. Logistic regression models were performed on categorical outcomes and a gamma-distributed model for continuous variables. All models were adjusted for patient demographics and comorbidities.
The inpatient readmission rates for the nonparticipating group when compared with the participating group were higher and demonstrated higher odds ratios (ORs) for 30-day inpatient readmissions (nonparticipating group 106/2636, 4.02% and participating group 54/2048, 2.64%; OR 1.48, 95% CI 1.03 to 2.13; P=.04), 60-day inpatient readmissions (nonparticipating group 194/2636, 7.36% and participating group 85/2048, 4.15%; OR 1.79, 95% CI 1.32 to 2.39; P<.001), and 90-day inpatient readmissions (nonparticipating group 261/2636, 9.90% and participating group 115/2048, 5.62%; OR 1.81, 95% CI 1.40 to 2.34; P<.001). The length of stay for the nonparticipating cohort was longer at 1.90 days, whereas the length of stay for the participating cohort was 1.50 days (mean 1.87, SD 2 vs mean 1.50, SD 1.37; P<.001). Patients treated by participating surgeons received and read text messages using mHealth 83% of the time and read emails 84% of the time. Patients responded to 60% of the text messages and 53% of the email surveys. Patients were least responsive to digital monitoring questions when the hospital asked them to do something, and they were most engaged with emails that did not require action, including informational content. A total of 96% (558/580) of patients indicated high satisfaction with using mHealth technology to support their care. Only 0.40% (75/2059) patients opted-out of the mHealth technology program after enrollment.
A novel, multicomponent, pathway-driven, patient-facing mHealth technology can positively impact patient outcomes and patient-reported experiences. These technologies can empower patients to play a more active and meaningful role in improving their outcomes. There is a deep need, however, for a better understanding of the interactions between patients, technology, and health care providers. Future research is needed to (1) help identify, address, and improve technology usability and effectiveness; (2) understand patient and provider attributes that support adoption, uptake, and sustainability; and (3) understand the factors that contribute to barriers of technology adoption and how best to overcome them.
尽管移动医疗(mHealth)的发展和媒体炒作声势浩大,但支持广泛实施 mHealth 技术的有效性的文献却很少。
本研究旨在评估具有多种重叠目的的创新 mHealth 技术系统是否可以影响(1)临床结果(即再入院率、复诊率和住院时间)和(2)以患者为中心的护理结果(即患者参与度、患者体验和患者满意度)。
我们将使用 mHealth 技术的参与骨科医生的所有患者(2059 名患者)与未参与骨科医生的所有患者(2554 名患者)进行比较。分析包括 Wilcoxon 秩和检验、连续变量的 Kruskal-Wallis 检验和分类变量的卡方检验。对分类结果进行逻辑回归模型分析,对连续变量进行伽马分布模型分析。所有模型均根据患者人口统计学特征和合并症进行调整。
与参与组相比,非参与组的住院患者 30 天内再入院率更高,且具有更高的比值比(OR)(非参与组 106/2636,4.02%和参与组 54/2048,2.64%;OR 1.48,95%CI 1.03 至 2.13;P=.04)、60 天内再入院率(非参与组 194/2636,7.36%和参与组 85/2048,4.15%;OR 1.79,95%CI 1.32 至 2.39;P<.001)和 90 天内再入院率(非参与组 261/2636,9.90%和参与组 115/2048,5.62%;OR 1.81,95%CI 1.40 至 2.34;P<.001)。非参与组的住院时间更长,为 1.90 天,而参与组的住院时间为 1.50 天(平均 1.87,SD 2 与平均 1.50,SD 1.37;P<.001)。接受参与医生治疗的患者使用 mHealth 接收和阅读短信的时间为 83%,阅读电子邮件的时间为 84%。患者对 60%的短信和 53%的电子邮件调查做出了回应。当医院要求患者采取行动时,患者对数字监测问题的反应最小,而他们对不需要采取行动的电子邮件(包括信息内容)最感兴趣。96%(558/580)的患者表示非常满意使用 mHealth 技术支持他们的护理。只有 0.40%(75/2059)的患者在登记后选择退出 mHealth 技术计划。
一种新颖的、多组分的、基于途径的、面向患者的 mHealth 技术可以积极影响患者的结果和患者报告的体验。这些技术可以使患者更积极、更有意义地参与改善他们的治疗结果。然而,我们非常需要更好地了解患者、技术和医疗保健提供者之间的相互作用。未来的研究需要(1)帮助确定、解决和提高技术的可用性和有效性;(2)了解支持采用、接受和可持续性的患者和提供者属性;(3)了解影响技术采用障碍的因素以及如何克服这些障碍。